Regeneron Hid Docs From USPTO, Judge Finds In Merus Case
Regeneron Pharmaceuticals Inc. withheld materials from the U.S. Patent and Trademark Office in order to secure a patent for genetically modified mice, a New York federal judge has found, adding yet...To view the full article, register now.
Already a subscriber? Click here to view full article